Drug
Lamazym
Lamazym: highest development phase Phase 3, developed by Chiesi Farmaceutici. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lamazym NCT02478840 | Phase 3 | Alpha-Mannosidosis |
| Lamazym NCT01908712 | Phase 3 | Alpha-Mannosidosis |
| Lamazym NCT01268358 | Phase 1 | Alpha Mannosidosis |
Latest
No recent events.
Follow Lamazym on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.